New Insights into Respiratory Diseases Caused by Substance Abuse
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Pulmonology".
Deadline for manuscript submissions: 25 September 2024 | Viewed by 141
Special Issue Editors
Interests: thoracic surgery; minimally invasive and robotic thoracic surgery; lung cancer; mediastinal tumors; pleural diseases; chest wall diseases; pediatric bronchoscopy; lung metastases; rare chest tumors
Interests: obstructive lung diseases; airway obstruction; chronic obstructive pulmonary disease (COPD); obstructive sleep apnea; pulmonary medicine; respiration disorders; spirometry; allergic asthma; asthma; allergic diseases
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Tobacco smoking, cannabis smoking, and drugs abuse are, nowadays, very common among young people. In the last few years, researchers have studied and pointed out the deleterious effects of tobacco and cannabis consumption on the respiratory system. The action of tobacco and/or cannabis on the airways may lead to hyperresponsiveness, inflammation, tissue destruction, and lung emphysema. Consequently, tobacco and/or cannabis abuse can cause upper and lower airways diseases, with acute and chronic manifestations and, among the latter, lung cancer represents a possible evolution. Pathogenesis studies investigating the detrimental effects of marijuana on the cells of the respiratory system are in progress. Campaigns for smoking prevention and for cessation of such voluptuary habits have an important role in limiting the spread of respiratory diseases caused by this abuse and an ethical and sociological relevance for young populations. In this Special Issue, we welcome authors to submit papers on recent and new insights into respiratory diseases caused by drugs or tobacco.
Dr. Angela De Palma
Dr. Silvano Dragonieri
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drugs
- cannabis
- smoking
- respiratory diseases
- prevention
- treatment
